|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2170390 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08771026.5 |
| Date of filing the European patent application | 2008-06-13 | |
| (97) | Date of publication of the European application | 2010-04-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation | 2019-01-10 |
| (86) | Number | PCT/US2008/066928 |
| Date | 2008-06-13 |
| (87) | Number | WO 2008/157356 |
| Date | 2008-12-24 |
| (30) | Number | Date | Country code |
| 944076 P | 2007-06-14 | US |
| (72) |
MALONEY, Kevin, US
|
| (73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Natalizumabo antikūnų kompozicijos |
| NATALIZUMAB ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 18 | 347.00 EUR |
| 2026-06-13 |